Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Janssen-cilag International Nv

Clinical trials sponsored by Janssen-cilag International Nv, explained in plain language.

Now part of Johnson & Johnson JNJ NYSE

Pharmaceutical subsidiary of Johnson & Johnson.

Trade on eToro (ad)

Not investment advice. Company information is shown for context only. Clinical trials frequently fail.

Not yet finished but already full! 1 Completed 1

Can psoriasis patients skip more shots? new trial tests extended guselkumab dosing

Disease control Completed

This study tested whether people with moderate-to-severe plaque psoriasis who achieve complete skin clearance after 20 weeks of guselkumab (Tremfya) can maintain that control with injections every 16 weeks instead of every 8 weeks. About 880 participants were enrolled, and the ma…

Phase: PHASE3 • Sponsor: Janssen-Cilag International NV • Aim: Disease control

Last updated Jun 27, 2026 08:13 UTC